Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa
Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa buy - large image1
Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa buy - image1
Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa buy - image2
Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa buy - image3
Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa buy - image4
Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa buy - image5
Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa buy - image6

Tirzepatide Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa

TDS 2099 Inquiries

Unit Price:

$1/G FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

gz

Brand:

TY

Packaging:

10mg/vial 10vials/box

Price valid (until):

2031-01-04

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Qualification:
Main Products:

semaglutide,tirzepatide,retatrutide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Sales manager:Wendy

    whatsapp:+86  17324564097

    Email:sales4ytpep@163.com


    What is Tirzepatide ?

        Tirzepatide (Tirzepatide) is a novel dual receptor agonist drug developed by Eli Lilly. It is mainly used for the treatment of type 2 diabetes and obesity. It simultaneously activates the   GIP (Glucose-dependent Polypeptide) and GLP-1 (Glucagon-like Peptide-1) hormone receptors. By enhancing secretion, inhibiting glucagon, delaying gastric emptying and increasing satiety, it significantly improves blood sugar control and promotes weight loss. Clinical trials have shown that its hypoglycemic and weight loss effects are superior to those of single-acting GLP-1 drugs (such as Semaglutide), and it has been approved for sale in the United States, Europe and other regions.

    Functions/Benefits
    1. Regulate blood sugar and treat type 2 diabetes
    (1) Promote secretion

        Teprotumumab precisely regulates secretion by activating GLP-1/GIP receptors in a glucose-dependent manner. It effectively controls post-meal hyperglycemia while avoiding the risk of hypoglycemia, achieving safe and long-lasting blood sugar management.
    (2) Inhibit glucagon secretion
       Teprotumumab inhibits glucagon secretion, reducing liver glucose production, effectively controlling fasting and post-meal blood sugar levels, and reducing organ damage caused by blood sugar fluctuations.
    2. Reduce weight, for long-term weight management
    (1) Suppress appetite and reduce calorie intake
       Tepolipide regulates the appetite signal bidirectionally by activating the central GLP-1/GIP receptors. It not only reduces hunger but also enhances satiety, thereby naturally reducing the intake of high-calorie foods and achieving a more sustainable weight loss effect.
    (2) Increase energy consumption and promote fat breakdown
        Tepolipide promotes the breakdown of visceral fat and maintains the basal metabolic rate by activating brown fat and improving metabolic efficiency. This enables more effective weight loss and reduces the risk of rebound.
    (3) Improve weight-related complications
       Tepolipide can simultaneously improve various metabolic complications such as hypertension, dyslipidemia, and fatty liver through weight loss and dual receptor action mechanisms, effectively reducing the risk of metabolic syndromShop Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa-Detailed Image 1 Shop Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa-Detailed Image 2 Shop Tirzepatide  Latest Technology Tirzepatide Lyophilized  Wrinkle Freeze Drying Powder-Detailed Image 1e.Shop Tirzepatide  Fast shipping CAS 2023788-19-2 Top GLP-1 Loss Weight Peptide Tirzepatide-Detailed Image 3 Shop Tirzepatide  Weight Loss Peptide Tirzepatide,Retatrutide, Cagrilintide, High Quality Lyophilized Powder-Detailed Image 3 Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 1 Shop Tirzepatide  Latest Technology Tirzepatide Lyophilized  Wrinkle Freeze Drying Powder-Detailed Image 3 Shop Tirzepatide  Latest Technology Tirzepatide Lyophilized  Wrinkle Freeze Drying Powder-Detailed Image 4 Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 2  Shop Tirzepatide  Weight Loss Freeze-dried powder tirzepatide Peptide Vials 5mg 10mg 15mg 20mg 30mg kits-Detailed Image 6 Shop Tirzepatide  Weight Loss Freeze-dried powder tirzepatide Peptide Vials 5mg 10mg 15mg 20mg 30mg kits-Detailed Image 7 Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 3 Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 4

    Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 5

    Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 6 Shop Tirzepatide  Latest Technology Tirzepatide Lyophilized  Wrinkle Freeze Drying Powder-Detailed Image 12

    ..Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 7

    Items Specifications
    Product name Tirzepatide
    CAS number 2023788-19-2
    Side Effect No
    Pharmaceutical Technology Custom Synthesis
    Efficacy Weight Loss & Slimming
    Purity > 99.5% by HPLC
    Storage Sealed Storage, Away From Moisture
    Clinical Trial Type 2 Diabetes|Obesity|Overweight
    Transport Package Vials
    Specification 5mg 10mg 15mg 20mg 30mg 50/60mg
    Origin China


      Company Profile 


    Our is an innovative enterprise dedicated to the research, development, and sales of peptide products. Since its establishment, we have always adhered to the business philosophy of "Technological Innovation, Quality First", focusing on providing efficient, safe, and customized peptide solutions for global customers. With advanced biosynthetic technology, a strict quality control system, and a professional research and development team, has continuously made breakthroughs in the peptide field and has become a leader in the industry.
    Our product line covers various fields such as pharmaceutical-grade peptides, cosmetic peptides, food-grade peptides, etc., which are widely used in new drug development, beauty and skincare, nutrition and health care, and many other aspects. Through continuous technological innovation and optimized services, we are committed to meeting the diverse needs of customers and promoting the continuous advancement of peptide application technology.
    insists on being customer-centric. We not only provide high-quality peptide products but also strive to offer comprehensive technical support and customized services to help customers excel in the market competition. In the future, we will continue to delve deeply into the peptide field, explore more possibilities, and contribute to human health and a better life.
    Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 8 Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 9 Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 10 Shop Tirzepatide  Weight LossTirzepatide  vial 10mg  Reta Peptide Semaglutide Tirzepatide HGH  BPC 157  TB500  GHK-CU  GLOW-Detailed Image 11

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates
    • Tirzepatide   Peptide Nad+ IV Infusion Coenzyme Nicotinamide Adenine Dinucleotide Sema Tirz Retatrutide Mt2 Semax Dihexa Certificates 1 TDS

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    semaglutide,tirzepatide,retatrutide

    Location:

    78 Dayuan Village, Jindian Town, Neiqiu County, Xingtai City

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    51-100

    Year of Establishment:

    2025


      Company Profile  


    Yingpeptides Technology Co., Ltd focuses on the research and development and production of high potency polypeptide products, targeting the global market, and provides polypeptide API/raw material and preparation products. It has built polypeptide API workshops, bio-fermentation workshops, polypeptide purification and lyophilization workshops, and multifunctional injection workshops that meet the GMP requirements of mainstream markets such as the U.S. FDA, EU EMA, Japanese PMDA, and China NMPA. With the strong support of New Hope Group, the company has introduced advanced large-scale CS-PREP® industrial preparative liquid chromatography systems, becoming one of the few polypeptide companies in the industry with a capacity of tons.



  • Inquiry History
    2099 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    United States

    Tirzepatide

    20 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    United States

    Tirzepatide

    50 MG Oct 20, 2026
    Spain

    tirzepatide

    20 MG Oct 19, 2026
    United States

    tirzepatide

    30 MG Oct 19, 2026
    Philippines

    tirzepatide

    40 MG Oct 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.